LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 51 filers reported holding LEGEND BIOTECH CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,149,723 | +5.4% | 361,202 | +8.2% | 0.00% | 0.0% |
| Q2 2023 | $22,905,055 | +48.3% | 333,789 | +3.7% | 0.00% | +50.0% |
| Q1 2023 | $15,445,451 | +114404.0% | 321,968 | +18.7% | 0.00% | 0.0% |
| Q4 2022 | $13,489 | -99.9% | 271,327 | +4.4% | 0.00% | 0.0% |
| Q3 2022 | $10,578,000 | -19.3% | 259,942 | +8.6% | 0.00% | 0.0% |
| Q2 2022 | $13,107,000 | +58.1% | 239,316 | +4.3% | 0.00% | +100.0% |
| Q1 2022 | $8,292,000 | -17.9% | 229,541 | +5.4% | 0.00% | 0.0% |
| Q4 2021 | $10,099,000 | +1167.1% | 217,822 | +1281.3% | 0.00% | – |
| Q3 2021 | $797,000 | +23.2% | 15,769 | 0.0% | 0.00% | – |
| Q2 2021 | $647,000 | +29.7% | 15,769 | -8.3% | 0.00% | – |
| Q1 2021 | $499,000 | +3.1% | 17,199 | 0.0% | 0.00% | – |
| Q4 2020 | $484,000 | +37.5% | 17,199 | +50.7% | 0.00% | – |
| Q3 2020 | $352,000 | -24.8% | 11,416 | +3.8% | 0.00% | – |
| Q2 2020 | $468,000 | – | 11,003 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |